Enron Mail

From:vladimir.gorny@enron.com
To:kevin.presto@enron.com, rogers.herndon@enron.com, tim.belden@enron.com,don.black@enron.com
Subject:EES Matters
Cc:
Bcc:
Date:Thu, 10 May 2001 12:42:00 -0700 (PDT)

Since I did not get a chance to meet with you yesterday, I would like to lay
out a few thoughts in this email:

1. Additional areas that might require immediate attention:

? Consider existing "Bets" and large positions already in the books and ways
of adjusting these bets, if necessary (excluding CA):
- NY: large short positions behind Central Hudson and ConEd (IBM deal and
others)
- Carolinas: Standard Offer timing (Springs, Eli Lily, others)
- Illinois: concentration of short regulated positions

? Quick handle on option positions: do we need to switch customers in some
areas? what options we ought to exercise tomorrow? next week? etc.
- options embedded in the deals
- regulatory switch options
- retail index options
- EAM options

? Managing value from restructuring legacy deals: in the process of reviewing
the 13 deals, we discovered some provisions in the contracts that were not
captured and managed properly - they might require immediate attention to
minimize losses in these deals.

2. Managing Regulatory Exposure

? Approximately 80% of EES regulatory exposure is behind 40 utilities
? In the process of rate case decomposition, we need to identify the main
components of each rate structure - create a rate case formula
? These components will fall into two categories: hedgeable (gas, coal,
heating oil fuel costs, inflation, etc.) and "unhedgeable" (CTC timing,
standard offer, etc.)

Hedgeable Component Unhedgeable Component
Strategy: Manage within the respective commodity books Capitalize on
portfolio diversification across the country
Look for "macro" hedges and focus activities of EGA

Pricing: You know best Risk-based: higher premiums for greater
uncertainty

Policy: Internal authorizations only on who, how and when to hedge Develop a
limit framework and propose a limit to the BOD

Exposure: Existing VaR model will suffice Develop and implement stress
scenarios to quantify exposure

3. Other Considerations

? Curve management: clear responsibilities, periodic review and validation
? Interaction with the EAM world: EAM projects create long positions, pricing
bundled deals with an EAM component
? Flash-to-actual catch up: liquidations validate curve assumptions
? Attention to EES-Canada: currently executed a power deal and a few gas deals
? Process for pricing smaller mid-market deals: sacrificing quantity for
quality - force originators to develop standard deal structures

I could elaborate further on these points. Vlady.